Today’s Solutions: June 11, 2026

Person in a white shirt holds a colorful plastic human anatomy model in front of their torso, showing internal organs.

A daily pill just doubled survival time for advanced pancreatic cancer

BY THE OPTIMIST DAILY EDITORIAL TEAM In a 500-patient trial at American Society of Clinical Oncology's (ASCO) annual meeting in Chicago, a daily pill called daraxonrasib doubled average survival time in patients with advanced pancreatic cancer. Those on the drug lived for an average of 13.2 Read More...